MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with Z

Zidovudine

Zidovudine 100mg capsules

Use with caution

Stability notes for Zidovudine 100mg capsules

Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.

Provenance

This compatibility recommendation is derived from Retrovir 100mg capsules (ViiV Healthcare UK Ltd)

Suppliers

Retrovir 100mg capsules (ViiV Healthcare UK Ltd)
Zidovudine 100mg capsules (Milpharm Ltd)

Zidovudine 250mg capsules

Use with caution

Stability notes for Zidovudine 250mg capsules

Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.

Provenance

This compatibility recommendation is derived from Retrovir 250mg capsules (ViiV Healthcare UK Ltd)

Suppliers

Retrovir 250mg capsules (ViiV Healthcare UK Ltd)
Zidovudine 250mg capsules (Milpharm Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.